395 POSTER Phase I study of XL844, a novel Chk1 and Chk2...

European Journal of Cancer Supplements 2008 Vol. 6; Iss. 12

395 POSTER Phase I study of XL844, a novel Chk1 and Chk2 kinase inhibitor, in combination with gemcitabine in patients with advanced malignancies

A. Tse, S. Yazji, A. Naing, D. Matthews, G. Schwartz, K. Lawhorn, R. Kurzrock
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)72329-2
File:
PDF, 57 KB
english, 2008
Conversion to is in progress
Conversion to is failed